Literature DB >> 28251968

[Frequency, spectrum, and functional significance of TP53 mutations in patients with diffuse large B-cell lymphoma].

E N Voropaeva1,2, T I Pospelova3, M I Voevoda1, V N Maksimov1.   

Abstract

A comparative analysis of oncogene mutations shows that variations in their frequency, spectrum, and hot-spot locations depends on the type of tumor and the ethnic origin of the population studied. The current version of the IARC TP53 Mutation Database lacks information about the frequency and spectrum of TP53 mutations in patients with DLBCL in Russia. The aim of this study was to assess the frequency and functional significance of TP53 mutations in patients with DLBCL in Novosibirsk. The TP53 coding sequence and the adjacent intron regions were analyzed by direct sequencing in the tumor material from 74 patients with DLBCL. Mutations of the TP53 coding sequence were found in 18 (24.3%) patients. These data are consistent with the frequency of TP53  mutations observed in other studies. The spectrum of nucleotide substitutions found in DLBCL specimens corresponded to that described in the IARC TP53 Mutation Database. According to bioinformatic data and to reported experiments in vitro, most of the mutations detected result in the production of functionally inactive p53. Our results show that DLBCL progression is accompanied by the functional selection for mutations in TP53 exons 5-8.

Entities:  

Keywords:  TP53 gene; diffuse large B-cell lymphoma; mutation; sequencing

Mesh:

Substances:

Year:  2017        PMID: 28251968     DOI: 10.7868/S0026898416060227

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  5 in total

1.  The rs78378222 prevalence and the copy loss of the protective allele A in the tumor tissue of diffuse large B-cell lymphoma.

Authors:  Elena N Voropaeva; Yuriy L Orlov; Tatiana I Pospelova; Anna A Gurageva; Mikhail I Voevoda; Vladimir N Maksimov; Olga B Seregina; Maria I Churkina
Journal:  PeerJ       Date:  2020-11-12       Impact factor: 2.984

2.  The Methylation of the p53 Targets the Genes MIR-203, MIR-129-2, MIR-34A and MIR-34B/C in the Tumor Tissue of Diffuse Large B-Cell Lymphoma.

Authors:  Elena N Voropaeva; Tatjana I Pospelova; Yuriy L Orlov; Maria I Churkina; Olga V Berezina; Anna A Gurazheva; Tatjana A Ageeva; Olga B Seregina; Vladimir N Maksimov
Journal:  Genes (Basel)       Date:  2022-08-07       Impact factor: 4.141

3.  TP53-Mutated Circulating Tumor DNA for Disease Monitoring in Lymphoma Patients after CAR T Cell Therapy.

Authors:  Liting Chen; Wei Mu; Jia Gu; Min Xiao; Liang Huang; Miao Zheng; Chunrui Li; Yi Xiao; Jianfeng Zhou; Xiaolu Long
Journal:  Diagnostics (Basel)       Date:  2021-05-08

4.  Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach.

Authors:  Mathilde R W de Jong; Lydia Visser; Gerwin Huls; Arjan Diepstra; Marcel van Vugt; Emanuele Ammatuna; Rozemarijn S van Rijn; Edo Vellenga; Anke van den Berg; Rudolf S N Fehrmann; Tom van Meerten
Journal:  PLoS One       Date:  2018-02-28       Impact factor: 3.240

Review 5.  Mitochondria and Their Relationship with Common Genetic Abnormalities in Hematologic Malignancies.

Authors:  Ibolya Czegle; Austin L Gray; Minjing Wang; Yan Liu; Jun Wang; Edina A Wappler-Guzzetta
Journal:  Life (Basel)       Date:  2021-12-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.